InvestorsObserver
×
News Home

Is Hookipa Pharma Inc (HOOK) a Good Choice in Biotechnology Tuesday?

Tuesday, December 26, 2023 09:52 AM | InvestorsObserver Analysts

Mentioned in this article

Is Hookipa Pharma Inc (HOOK) a Good Choice in Biotechnology Tuesday?

A rating of 79 puts Hookipa Pharma Inc (HOOK) near the top of the Biotechnology industry according to InvestorsObserver. Hookipa Pharma Inc's score of 79 means it scores higher than 79% of stocks in the industry. Hookipa Pharma Inc also received an overall rating of 62, putting it above 62% of all stocks. Biotechnology is ranked 41 out of the 148 industries.

Overall Score - 62
HOOK has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on HOOK!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 62 means the stock is more attractive than 62 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Hookipa Pharma Inc Stock Today?

Hookipa Pharma Inc (HOOK) stock is unmoved -0.44% while the S&P 500 has risen 0.25% as of 9:50 AM on Tuesday, Dec 26. HOOK is unchanged $0.00 from the previous closing price of $0.72 on volume of 404,394 shares. Over the past year the S&P 500 is higher by 24.48% while HOOK has fallen -1.37%. HOOK lost -$0.99 per share the over the last 12 months. Click Here to get the full Stock Report for Hookipa Pharma Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App